EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Assessing Severity of Disease in Patients with Ulcerative Colitis

Baldeep Singh Pabla, David Allen Schwartz

Gastroenterology Clinics of North America · 2020-12 · 49 (4) · 671-688

DOI: 10.1016/j.gtc.2020.08.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Gastroenterology Clinics of North America, 2020-12. Verfasst von Baldeep Singh Pabla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Suite 220, 1211 21st Avenue South, Nashville, TN 372…. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 147-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Janssen Pharmaceuticals, Pfizer, Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic disease that can present at various stages of disease activity and severity. Traditionally, severity scoring has focused on disease activity during a single moment with various tools, including patient-reported symptoms, as well as clinical, laboratory-based, endoscopic, histologic, and imaging variables. Optimal delivery of care depends on the accurate assessment of disease severity, which must take longitudinal variables into account. This article reviews the history of severity scoring in UC and provides a concise, clinically oriented approach to assessing disease severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignColectomyColitis, UlcerativeEndoscopy, GastrointestinalEvidence-Based PracticeForecastingHumansSeverity of Illness IndexTreatment Outcome

Stichwörter der Autor:innen

CRPClostridium difficileMayo scorePROTruelove and WittsUCEIS

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Suite 220, 1211 21st Avenue South, Nashville, TN 37232-5280, USA. Electronic address: baldeep.pabla@vumc.org.
  • Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Suite 220, 1211 21st Avenue South, Nashville, TN 37232-5280, USA. Electronic address: https://twitter.com/ibddoc09.

Förderung

  • Janssen Pharmaceuticals
  • Pfizer
  • Gilead Sciences
  • School of Public Health, University of California Berkeley
  • AbbVie

Zitieren

APA

Pabla, B. S., & Schwartz, D. A. (2020). Assessing Severity of Disease in Patients with Ulcerative Colitis. Gastroenterology Clinics of North America, 49(4), 671-688. https://doi.org/10.1016/j.gtc.2020.08.003

Vancouver

Pabla BS, Schwartz DA. Assessing Severity of Disease in Patients with Ulcerative Colitis. Gastroenterology Clinics of North America. 2020;49(4):671-688. doi:10.1016/j.gtc.2020.08.003

BibTeX
@article{Pabla2020,
  author = {Pabla, Baldeep Singh and Schwartz, David Allen},
  title = {Assessing Severity of Disease in Patients with Ulcerative Colitis},
  journal = {Gastroenterology Clinics of North America},
  year = {2020},
  volume = {49},
  number = {4},
  pages = {671--688},
  doi = {10.1016/j.gtc.2020.08.003}
}
Kostenlos starten →